136 results
Page 2 of 7
8-K
EX-10.1
1gc84 wbv
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
EX-2.2
6y88wvpczhwkliab0c
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-4
lfqfyjq8azwh006ij
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
971j 6pnd
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
c5tdm6u9pzpr8nwhq
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-10.1
6huunf6dznip2twa i81
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
8l14uh 0c
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm